Ophthalmology Times Europe - Latest news in cataract, refractive, retina, glaucoma and more

ADVERTISEMENT

SEARCH
  • home
  • about us
  • contact us
  • subscribe
  • media kit request
 

CATARACT

GLAUCOMA

REFRACTIVE

RETINA

Saturday, 04 July 2009
Job opportunities
Research opportunities
Useful linksCurrent survey

ADVERTISEMENT

Drug therapy for macular oedema treatment approved
June 24, 2009
Ozurdex, the first drug therapy for the treatment of macular oedema, following branch retinal vein occlusion or central retinal vein occlusion, has been approved by the FDA.
Regimen change cuts eye drops use in half
June 24, 2009
Nerve damage associated ocular dryness improved dramatically with hyaluronic acid-based lubricating eye drops explains Claes Feinbaum M.Sc. Professor Emeritus Optometry, Vision4You, Lund, Sweden.
Gene therapies
June 24, 2009
Ocular applications of gene therapies are increasing, as is our understanding of the molecular pathogenesis of glaucoma.
New fluidics concept
June 24, 2009
Oertli has developed a new phaco tip, easyTip2.2mm, based on the design of the CO-MICS 2. It uses a new fluidics concept with a high vacuum setting and a wide infusion path, creating a strong axially directed flow.
High viscosity eye drop improves T-BUT in VDT users
June 24, 2009
High molecular weight increases blink rate and helps eye drops retain moisture on the ocular surface according to Professor Giancarlo Montani an optometrist FIACLE and a professor of optometry at the Universita del Salento in Italy.
Tweet!
    follow OTE on Twitter
    June 2009
    Glaucoma
    SLT's successful clinical implementation will rank among ophthalmology's milestones
    By: Dr Cornelia Hirn, Dr Sandrine Zweifel, Madhu Nagar, MS Ophth, FRCS Ophth (Ed), Professor Jens Funk, Lawrence Jindra, Karin Hornykewycz, MD
    RNFL analysis by OCT... onto the next level for glaucoma diagnosis
    By: Dr Chandrima Paul
    Successfully treating ultra-refractory glaucoma patients
    By: Martin Uram, MD, MPH
    Cataract & Refractive
    Aberration comparison between two silicone lenses
    By: Roberto Bellucci, MD
    Initial experience with a toric lens
    By: Han Bor Fam, FRCSE, Kooi Ling Lam, B. Optom
    New research points to progress on the HOA front
    By: Jack T. Holladay, MD, MSEE, FACS
    RNFL thickness after LASIK, LASEK and PRK
    By: Miguel Lume, Ramiro Salgado, F. Vaz, MD, Dr M.C. Pinto, Dr M.J. Furtado, Dr P. Reimao
    Retina
    Sutureless transconjunctival 20 g pars plana vitrectomy
    By: Eustratios Gotzaridis, MD
    Cornea
    Treating corneal neovascularisation with an anti-VEGF
    By: Terry Kim, MD, Ricardo Santaella, MD
    May 2009
    News
    News, May 2009
    Presbyopia
    IOLs for the ageing eye
    By: Thomas Hofman, MS, Eduard Haefliger, MD
    Glaucoma
    It's never too late to learn new skills
    By: Clive Peckar, MSc, Matthias Grieshaber, MD
    Cataract & Refractive
    Can you reduce oxidative stress during phaco?
    By: Steven D. Aust, PhD
    Pain perceptions during cataract surgery
    By: Dr Andreas Borkenstein, Professor Gerd Auffarth
    Can variable IOL diameter result in improved fitting
    By: Professor Michael Georgopoulos
    Retina
    Diabetic macular oedema after phacoemulsification
    By: Victoria Farrell, Ken Hayashi, MD
    An assessment of neovascular AMD activity
    By: Sengul Ozdek, MD
    Cornea
    New technique for endothelial grafts
    By: Massimo Busin, MD
    From the Forum
    Keeping an eye on social media
    By: European Ophthalmology forum members
    Ophthalmology Times Europe is the independent source for current developments and best practices in European Ophthalmology. It is the balanced and unbiased forum for ophthalmologists to communicate practical experience, clinical knowledge, discoveries and applications, thereby promoting improvements in medical medical practice and patient health.
    Serving Europe's ophthalmic community
    Make This Page Your Home Page!
    Survey
    Will the recent results from Novartis' combination therapy trial for AMD deter ophthalmologists from administering this regimen to AMD patients?
    Yes
    No
    Yes
    54%
    No
    46%
    View Results
    Thank you for voting
    Newsletter sign-up
    Supplements
    View OTE's supplements
    Amazon book shop

    ADVERTISEMENT

    Click here